Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Boston Scientific Corp (BSX) Insider Trading Activity
Healthcare • Medical Devices • 48,000 employees
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Total Value
-$53,725,456.91
Total Shares
-243,447
Average Trade Value
-$1,119,280.35
Most Active Insider
Mahoney Michael F
Total Activity: $46,417,986
Largest Single Transaction
$13,573,743
by Mahoney Michael F on Nov 5, 2024
30-Day Activity
4 Transactions
Volume: 4,056 shares
Value: $672,716
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
---|---|---|---|---|---|---|
Evp, Human Resources
Officer
|
Dec 2, 2024 | 6,983 | $633,917 | 29,308 (-23.8%) | Sale | |
Evp, Human Resources
Officer
|
Dec 2, 2024 | 1,197 | $29,386 | 36,291 (+3.3%) | Exercise/Conversion | |
Evp, Human Resources
Officer
|
Dec 2, 2024 | 3,066 | $52,919 | 35,094 (+8.7%) | Exercise/Conversion | |
Svp, Global Controller and Cao
Officer
|
Nov 27, 2024 | 1,336 | $121,105 | 2,957 (-45.2%) | Sale | |
EVP Grp Pres, Medsurg Apac
Officer
|
Nov 25, 2024 | 1,009 | $17,415 | 14,988 (+6.7%) | Exercise/Conversion | |
EVP Grp Pres, Medsurg Apac
Officer
|
Nov 25, 2024 | 14,010 | $1,250,664 | 978 (-1432.5%) | Sale | |
EVP Grp Pres, Medsurg Apac
Officer
|
Nov 25, 2024 | 3,177 | $72,150 | 13,979 (+22.7%) | Exercise/Conversion | |
Director
|
Nov 21, 2024 | 4,877 | $446,902 | 39,398 (-12.4%) | Sale | |
Evp, Global Operations
Officer
|
Nov 8, 2024 | 17,362 | $426,237 | 70,286 (+24.7%) | Exercise/Conversion | |
Evp, Global Operations
Officer
|
Nov 8, 2024 | 30,580 | $2,680,572 | 39,706 (-77.0%) | Sale | |
Chairman, President CEO
Director, Officer
|
Nov 5, 2024 | 56,211 | $970,202 | 1,628,307 (+3.5%) | Exercise/Conversion | |
Chairman, President CEO
Director, Officer
|
Nov 5, 2024 | 55,676 | $908,076 | 1,683,983 (+3.3%) | Exercise/Conversion | |
Chairman, President CEO
Director, Officer
|
Nov 5, 2024 | 2,596 | $221,108 | 1,681,387 (-0.2%) | Sale | |
Chairman, President CEO
Director, Officer
|
Nov 5, 2024 | 160,182 | $13,573,743 | 1,521,205 (-10.5%) | Sale | |
Evp, Human Resources
Officer
|
Nov 1, 2024 | 1,197 | $29,386 | 39,011 (+3.1%) | Exercise/Conversion | |
Evp, Human Resources
Officer
|
Nov 1, 2024 | 6,983 | $588,876 | 32,028 (-21.8%) | Sale | |
Evp, Human Resources
Officer
|
Nov 1, 2024 | 3,066 | $52,919 | 37,814 (+8.1%) | Exercise/Conversion | |
EVP Group Pres, Cardiology
Officer
|
Oct 7, 2024 | 57,618 | $1,439,298 | 292,994 (+19.7%) | Exercise/Conversion | |
EVP Group Pres, Cardiology
Officer
|
Oct 7, 2024 | 132,527 | $11,264,888 | 160,467 (-82.6%) | Sale | |
Chairman, President CEO
Director, Officer
|
Oct 7, 2024 | 55,675 | $908,059 | 1,734,873 (+3.2%) | Exercise/Conversion | |
EVP Group Pres, Cardiology
Officer
|
Oct 7, 2024 | 59,021 | $1,018,702 | 235,376 (+25.1%) | Exercise/Conversion | |
Chairman, President CEO
Director, Officer
|
Oct 7, 2024 | 82,085 | $6,972,431 | 1,572,096 (-5.2%) | Sale | |
Chairman, President CEO
Director, Officer
|
Oct 7, 2024 | 80,692 | $6,803,360 | 1,654,181 (-4.9%) | Sale | |
Chairman, President CEO
Director, Officer
|
Oct 7, 2024 | 56,211 | $970,202 | 1,679,198 (+3.3%) | Exercise/Conversion | |
Evp, Human Resources
Officer
|
Oct 1, 2024 | 3,066 | $52,919 | 40,534 (+7.6%) | Exercise/Conversion | |
Evp, Human Resources
Officer
|
Oct 1, 2024 | 6,983 | $585,594 | 34,748 (-20.1%) | Sale | |
Evp, Human Resources
Officer
|
Oct 1, 2024 | 1,197 | $29,386 | 41,731 (+2.9%) | Exercise/Conversion | |
Chairman, President CEO
Director, Officer
|
Sep 5, 2024 | 162,777 | $13,212,544 | 1,622,987 (-10.0%) | Sale | |
Chairman, President CEO
Director, Officer
|
Sep 5, 2024 | 56,211 | $970,202 | 1,730,089 (+3.2%) | Exercise/Conversion | |
Chairman, President CEO
Director, Officer
|
Sep 5, 2024 | 55,675 | $908,059 | 1,785,764 (+3.1%) | Exercise/Conversion | |
Evp, Human Resources
Officer
|
Sep 3, 2024 | 1,197 | $29,386 | 44,451 (+2.7%) | Exercise/Conversion | |
Evp, Human Resources
Officer
|
Sep 3, 2024 | 6,983 | $570,511 | 37,468 (-18.6%) | Sale | |
Evp, Human Resources
Officer
|
Sep 3, 2024 | 3,066 | $52,919 | 43,254 (+7.1%) | Exercise/Conversion | |
EVP Group Pres, Cardiology
Officer
|
Aug 28, 2024 | 14,132 | $1,130,560 | 176,355 (-8.0%) | Sale | |
EVP Grp Pres, Medsurg Apac
Officer
|
Aug 26, 2024 | 1,009 | $17,415 | 24,814 (+4.1%) | Exercise/Conversion | |
EVP Grp Pres, Medsurg Apac
Officer
|
Aug 26, 2024 | 3,176 | $72,127 | 23,805 (+13.3%) | Exercise/Conversion | |
EVP Grp Pres, Medsurg Apac
Officer
|
Aug 26, 2024 | 14,012 | $1,110,515 | 10,802 (-129.7%) | Sale | |
EVP Grp Pres, Medsurg Apac
Officer
|
Aug 6, 2024 | 10,843 | $799,780 | 13,381 (-81.0%) | Discretionary Transaction | |
Director
|
Aug 1, 2024 | 2,155 | $161,981 | 2,295 (+93.9%) | Grant | |
Evp, Human Resources
Officer
|
Aug 1, 2024 | 3,066 | $52,919 | 45,974 (+6.7%) | Exercise/Conversion | |
Director
|
Aug 1, 2024 | 1,252 | $94,175 | 3,547 (+35.3%) | Grant | |
Evp, Human Resources
Officer
|
Aug 1, 2024 | 6,983 | $517,580 | 40,188 (-17.4%) | Sale | |
Evp, Human Resources
Officer
|
Aug 1, 2024 | 1,197 | $29,386 | 47,171 (+2.5%) | Exercise/Conversion | |
Evp, Human Resources
Officer
|
Jul 1, 2024 | 6,983 | $539,786 | 42,908 (-16.3%) | Sale | |
Evp, Human Resources
Officer
|
Jul 1, 2024 | 3,066 | $52,919 | 48,694 (+6.3%) | Exercise/Conversion | |
Svp, Gc and Corp. Secretary
Officer
|
Jul 1, 2024 | 4,036 | $0 | 36,362 (+11.1%) | Exercise/Conversion | |
Svp, Gc and Corp. Secretary
Officer
|
Jul 1, 2024 | 1,952 | $149,152 | 34,410 (-5.7%) | Payment of Exercise Price | |
Evp, Human Resources
Officer
|
Jul 1, 2024 | 1,197 | $29,386 | 49,891 (+2.4%) | Exercise/Conversion |